Who owns PFE
2,831 institutions reported holding PFE for 2026Q1, together 65% of the company, fewer than the 2,833 a quarter earlier.
2,831
Institutions reporting a position · as of 2026Q1 · down from 2,833 the quarter before
- Shares held by institutions
- 3727.4M
Shares held by institutions · 65% of the company · long US equity positions only, as reported on Form 13F
- Reported value
- $104.6B
Reported value · at 2026-03-31 prices, not today's
- Top 5 holders
- 28%
Top 5 holders · of the whole company, between five filers
Details›
- Reporting quarter2026-03-31
- 2026Q1
- Quarters on record
- 52
- New positions
- 228
- Positions exited
- 236
- Added to
- 1,137
- Reduced
- 969
- Top 10 holdersof the company
- 33%
| Quarter | Filers | Shares | Reported value |
|---|---|---|---|
| 2026Q1 | 2,831 | 3727.4M | $104.6B |
| 2025Q4 | 2,833 | 3719.3M | $92.6B |
| 2025Q3 | 2,756 | 3609.3M | $91.9B |
| 2025Q2 | 2,752 | 3710.7M | $90.3B |
| 2025Q1 | 2,878 | 3734.0M | $96.8B |
| 2024Q4 | 2,941 | 3737.0M | $99.1B |
| 2024Q3 | 2,869 | 3747.9M | $108.5B |
| 2024Q2 | 2,836 | 3725.5M | $104.6B |
| 2024Q1 | 2,823 | 3778.7M | $104.8B |
| 2023Q4 | 2,884 | 3859.2M | $111.1B |
| 2023Q3 | 2,874 | 3888.7M | $130.4B |
| 2023Q2 | 2,990 | 3909.1M | $144.9B |
| 2023Q1 | 3,054 | 3908.9M | $160.9B |
| 2022Q4 | 3,211 | 3903.3M | $200.2B |
| 2022Q3 | 3,037 | 3868.5M | $169.6B |
| 2022Q2 | 3,110 | 3847.6M | $201.8B |
| Holder | Shares | % of company | Value |
|---|---|---|---|
| VANGUARD GROUP INC | 545.9M | 9.5% | $15.3B |
| BlackRock Inc. | 498.3M | 8.7% | $14.0B |
| STATE STREET CORP | 301.6M | 5.3% | $8.47B |
| GEODE CAPITAL MANAGEMENT LLC | 133.6M | 2.3% | $3.74B |
| Fisher Asset Management, LLC | 105.0M | 1.8% | $2.95B |
| MORGAN STANLEY | 92.7M | 1.6% | $2.60B |
| NORTHERN TRUST CORP | 62.0M | 1.1% | $1.74B |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 56.9M | 0.99% | $1.62B |
| STATE FARM MUTUAL AUTOMOBILE INSURANCE CO | 54.5M | 0.95% | $1.53B |
| Bank of New York Mellon Corp | 53.9M | 0.94% | $1.51B |
SEC Form 13F data sets (DERA bulk files). 13F is quarterly, filed up to 45 days late, and covers long US equity positions only, no shorts, no derivatives, nothing held below the reporting threshold.
reading the register…
Drug Manufacturers - General
Ranks #14 of 16 by Smart Score